News | Kayothera

KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million

Jul 19, 2023 | News, Press Release

New funding comprised of grants from the National Institutes of Health, The Andy Hill Cancer Research Endowment (CARE) Fund, and additional Equity Funding Additional funding will support advancement of KayoThera’s development programs in diabetes and oncology...

Kayothera Announces Expansion to Type 2 Diabetes with New Pipeline Addition

May 18, 2023 | News

Kayothera, an early-stage therapeutics company developing 1st-in-class, orally-available antagonists of the retinoid pathway, announces that it is advancing a program to treat and reverse cardiometabolic diseases, with a focus on Type 2 Diabetes. The clinical use of...

Kayothera, Inc. and Columbia University Announce Publication in Nature Communications Detailing Novel Therapeutic Strategy for Type 2 Diabetes

Feb 2, 2023 | News, Press Release

Seattle, WA — February 02, 2023, A paper published today in the peer-reviewed journal Nature Communications, co-authored by researchers from Columbia University, Kayothera, Inc., and Princeton University, describes a new therapeutic strategy for treatment of type 2...

Kayothera Founder Presented with Princeton University’s Tiger Entrepreneur Award

Oct 18, 2022 | News

Princeton Entrepreneurship Council is pleased to announce the winners of the 2022 Tiger Entrepreneur Award. For the last six years, the Tiger Entrepreneur Award has been given to celebrate the value of entrepreneurship across the Princeton community and to emphasize...

KayoThera, Inc. Raises $8 Million in Series A Financing Led by Accelerator Life Science Partners to Develop Novel Cancer Immunotherapeutics

Mar 16, 2022 | News, Press Release

Novel Approach to Treat Late-Stage and Metastatic Cancers SEATTLE, WA – March 16, 2022, KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing novel cancer immunotherapies, today announces the closing of an $8 million Series A round of...

KayoThera selected as a finalist in TechUnited’s Propelify Event

Oct 5, 2021 | News

Kayothera was selected as one of four finalists in this year’s Propelify event, a premier event celebrating technology and innovation in the tri-state area. Kayothera will be pitching at the BetterWellness challenge at 1:10 pm on October 6. The judges will award...

« Older Entries

Next Entries »